Pacira BioSciences (PCRX) Earnings Analysis
Pacira BioSciences (PCRX) has no confirmed upcoming earnings date. Last quarter (2026-04-30) it missed with EPS 0.6 USD vs 0.61 USD est (-1.6%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 209.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PCRX next report earnings?
No confirmed upcoming earnings date is currently scheduled for PCRX. This page updates as the calendar is published.
PCRX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.6 USD | 0.61 USD | -1.6% | Miss |
| 2026-02-26 | 0.57 USD | 0.85 USD | -32.9% | Miss |
| 2025-11-06 | 0.7 USD | 0.65 USD | +7.7% | Beat |
| 2025-02-27 | 0.91 USD | 0.78 USD | +16.7% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
PCRX valuation and analyst view
| Trailing P/E | 209.58 |
|---|---|
| Trailing EPS | 0.12699 USD |
| Price / book | 1.58 |
| Dividend yield | 0.00% |
| Market cap | 1.00B |
| Analyst consensus | Hold (15 buy / 17 hold / 4 sell) |
| Avg price target | 32 USD |
Related research pages
Frequently asked questions
When is Pacira BioSciences (PCRX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for PCRX. This page updates as the calendar is published.
Did PCRX beat earnings last quarter?
In its 2026-04-30 report, PCRX posted EPS of 0.6 USD versus a 0.61 USD estimate — a miss of 1.6%.
What is PCRX's earnings track record?
Over the last 4 reported quarters with consensus data, PCRX beat estimates 2 times (50%).
What is PCRX's current P/E ratio and EPS?
PCRX trades at a trailing P/E of 209.58 on trailing EPS of 0.12698648080867997 USD.
What do analysts rate PCRX?
Analyst consensus is "Hold" across 36 ratings (0 strong buy, 15 buy, 17 hold, 4 sell, 0 strong sell). Average 12-month price target: 32 USD.